APRIL in systemic lupus erythematosus: essential or dispensable? Comment on the article by Jacob et al

Arthritis Rheum. 2012 Jun;64(6):2052-3; author reply 2053. doi: 10.1002/art.34388. Epub 2012 Jan 13.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Animals
  • B-Cell Activating Factor / deficiency*
  • Lupus Erythematosus, Systemic / immunology*
  • Tumor Necrosis Factor Ligand Superfamily Member 13 / deficiency*

Substances

  • B-Cell Activating Factor
  • Tumor Necrosis Factor Ligand Superfamily Member 13